The National Medical Products Administration has approved the listing of Doxofylline Hydrochloride tablets.

Recently, the National Medical Products Administration approved the application of Yangtze River Pharmaceutical Group Co., Ltd. to market the innovative drug Tuonodafin hydrochloride tablets. This drug is used to treat erectile dysfunction, providing patients with a new treatment option.